Skip to main content
OpenTrials
Completed

NCT Number: NCT06594237

Maternal And Fetal Outcomes in Pregnant Women With Liver Disease

Liver disease complications during pregnancy can impact maternal and neonatal health, though not many studies are on view to investigate maternal and fetal outcomes in Pakistani pregnant women. So, this study was aimed to determine the maternal and fetal outcomes among pregnant females with liver disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Nishtar Medical University

Multan, Punjab Province, 66000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant females with liver disease
  • With gestational age > 24 weeks
  • Any parity or gravidity status

Exclusion criteria

  • Pregnant females with renal disease or any kind of malignancy

Treatment and study plan

Primary outcomes

  1. Maternal or Fetal survival or mortality.

    Time frame: 24 hours

    Fetal and maternal outcomes in terms of survival or death were noted.

Sponsors and collaborators

Lead sponsor

Muhammad Aamir Latif

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.